Parliament sides with Commission to approve controversial new antimicrobials rules

  17 September 2021

The European Parliament has given its green light to a controversial new antimicrobials regulation, dismissing a motion calling for tighter restrictions on antibiotics use in animals and allowing the Commission to move forward on its plans to tackle anti-microbial resistance.

Lawmakers gave their blessing to the Commission’s delegated act on Thursday (16 September), which is designed to tackle the burgeoning issue of anti-microbial resistance (AMR).

The act, which was presented back in May, proposes criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans, as advised by the European Medicines Agency and supported by EU governments.

A key priority for the Commission, AMR is the ability of microorganisms to resist antimicrobial treatments, especially antibiotics.

Further reading: Euractiv
Author(s): Benjamin Fox
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!